Size-Dependent Biodistribution of Fluorescent Furano-Allocolchicinoid-Chitosan Formulations in Mice

Overview

Journal Polymers (Basel)

Publisher MDPI

Date 2021 Jul 2

PMID 34206673

Citations 3

Authors

Iuliia Gracheva

Maria Konovalova

Dmitrii Aronov

Ekaterina Moiseeva

Alexey Fedorov

Elena Svirshchevskaya

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to compare the biodistribution in mice of functionalized rhodamine B (Rh) labeled colchicine derivative furano-allocolchicinoid (, ) either conjugated to 40 kDa chitosan (, ) or encapsulated into chitosan nanoparticles (). AC-NPs were formed by ionotropic gelation and were 400-450 nm in diameter as estimated in mice by dynamic light scattering and confocal microscopy. AC-Chi and AC-NPs preserved the specific colchicine activity in vitro. AC preparations were once IV injected into C75BL/6 mice; muscles, spleen, kidney, liver, lungs, blood cells and serum were collected at 30 min, 2, 5, 10, and 20 h post injection. To analyze the distribution of the furano-allocolchicinoid preparations in body liquids and tissues, Rh was measured directly in sera or extracted by acidic ethanol from tissue homogenates. Preliminary Rh extraction rate was estimated in vitro in tissue homogenates and was around 25-30% from total quantity added. After in vivo injection, AC-NPs were accumulated more in liver and spleen, while less in kidney and lungs in comparison with free AC and AC-Chi. Therefore, incorporation of colchicine derivatives as well as other hydrophobic substances into nano/micro sized carriers may help redistribute the drug to different organs and, possibly, improve antitumor accumulation.

Citing Articles

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.

Kalinovsky D, Kibardin A, Kholodenko I, Svirshchevskaya E, Doronin I, Konovalova M J Immunother Cancer. 2022; 10(6).

PMID: 35764367 PMC: 9240879. DOI: 10.1136/jitc-2022-004646.

Design and Manufacture of a Low-Cost Microfluidic System for the Synthesis of Giant Liposomes for the Encapsulation of Yeast Homologues: Applications in the Screening of Membrane-Active Peptide Libraries.

Gomez S, Quezada V, Quiroz I, Munoz-Camargo C, Osma J, Reyes L Micromachines (Basel). 2021; 12(11).

PMID: 34832789 PMC: 8619280. DOI: 10.3390/mi12111377.

Fluorescent Chitosan Modified with Heterocyclic Aromatic Dyes.

Kaczmarek H, Tafelska-Kaczmarek A, Roszek K, Czarnecka J, Jedrzejewska B, Zblewska K Materials (Basel). 2021; 14(21).

PMID: 34771955 PMC: 8585458. DOI: 10.3390/ma14216429.

References

Gracheva I, Voitovich I, Faerman V, Sitnikov N, Myrsikova E, Schmalz H . Synthesis and cytostatic properties of polyfunctionalized furanoallocolchicinoids. Eur J Med Chem. 2016; 126:432-443. DOI: 10.1016/j.ejmech.2016.11.020. View

Onoue S, Yamada S, Chan H . Nanodrugs: pharmacokinetics and safety. Int J Nanomedicine. 2014; 9:1025-37. PMC: 3934594. DOI: 10.2147/IJN.S38378. View

Leung Y, Hui L, Kraus V . Colchicine--Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015; 45(3):341-50. PMC: 4656054. DOI: 10.1016/j.semarthrit.2015.06.013. View

Nguyen T, Francis M . Practical synthetic route to functionalized rhodamine dyes. Org Lett. 2003; 5(18):3245-8. DOI: 10.1021/ol035135z. View

Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios D, Avgoustakis K . Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm. 2001; 221(1-2):143-52. DOI: 10.1016/s0378-5173(01)00676-7. View

AbouAitah K, Hassan H, Swiderska-Sroda A, Gohar L, Shaker O, Wojnarowicz J . Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles. Cancers (Basel). 2020; 12(1). PMC: 7017376. DOI: 10.3390/cancers12010144. View

Ediriwickrema A, Saltzman W . Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies. ACS Biomater Sci Eng. 2015; 1(2):64-78. PMC: 4426346. DOI: 10.1021/ab500084g. View

Kumar A, Sharma P, Mondhe D . Potential anticancer role of colchicine-based derivatives: an overview. Anticancer Drugs. 2016; 28(3):250-262. DOI: 10.1097/CAD.0000000000000464. View

Slobodnick A, Shah B, Pillinger M, Krasnokutsky S . Colchicine: old and new. Am J Med. 2015; 128(5):461-70. PMC: 4684410. DOI: 10.1016/j.amjmed.2014.12.010. View

10.

Nascimento A, Gattacceca F, Singh A, Bousbaa H, Ferreira D, Sarmento B . Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models. Nanomedicine (Lond). 2016; 11(7):767-81. PMC: 4910968. DOI: 10.2217/nnm.16.14. View

11.

Illum L . Nasal drug delivery - recent developments and future prospects. J Control Release. 2012; 161(2):254-63. DOI: 10.1016/j.jconrel.2012.01.024. View

12.

Haberkorn U, Krems B, Gerlach L, Bachert P, Morr I, Wiessler M . Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo 31P NMR and in vitro uptake experiments. Magn Reson Med. 1998; 39(5):754-61. DOI: 10.1002/mrm.1910390513. View

13.

Das G, Rao G, Wilson R, Chandy T . Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv. 2000; 7(3):129-38. DOI: 10.1080/10717540050120160. View

14.

Erfani M, Shamsaei M, Mohammadbaghery F, Shirmardi S . Synthesis and evaluation of a 99mTc-labeled tubulin-binding agent for tumor imaging. J Labelled Comp Radiopharm. 2014; 57(6):419-24. DOI: 10.1002/jlcr.3200. View

15.

Gracheva I, Shchegravina E, Schmalz H, Beletskaya I, Fedorov A . Colchicine Alkaloids and Synthetic Analogues: Current Progress and Perspectives. J Med Chem. 2020; 63(19):10618-10651. DOI: 10.1021/acs.jmedchem.0c00222. View

16.

Niel E, Scherrmann J . Colchicine today. Joint Bone Spine. 2006; 73(6):672-8. DOI: 10.1016/j.jbspin.2006.03.006. View

17.

Buschmann M, Merzouki A, Lavertu M, Thibault M, Jean M, Darras V . Chitosans for delivery of nucleic acids. Adv Drug Deliv Rev. 2013; 65(9):1234-70. PMC: 7103275. DOI: 10.1016/j.addr.2013.07.005. View

18.

Ho L, Hsu C, Ou C, Wang C, Liu T, Hwang L . Unibody core-shell smart polymer as a theranostic nanoparticle for drug delivery and MR imaging. Biomaterials. 2014; 37:436-46. DOI: 10.1016/j.biomaterials.2014.10.006. View

19.

Johansson E, Dubois J, Darbre T, Reymond J . Glycopeptide dendrimer colchicine conjugates targeting cancer cells. Bioorg Med Chem. 2010; 18(17):6589-97. DOI: 10.1016/j.bmc.2010.04.026. View

20.

Flaten G, Chang T, Phillips W, Brandl M, Bao A, Goins B . Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution. J Liposome Res. 2012; 23(1):70-81. DOI: 10.3109/08982104.2012.742537. View